Insulin signaling via Akt2 switches plakophilin 1 function from stabilizing cell adhesion to promoting cell proliferation

Journal of Cell Science

Volumn 126, Issue 8, 2013, Pages 1832-1844

  Wolf, Annika ^a   Rietscher, Katrin ^a   Glaß, Markus ^a   Hüttelmaier, Stefan ^a   Schutkowski, Mike ^a   Ihling, Christian ^a   Sinz, Andrea ^a   Wingenfeld, Aileen ^a   Mun, Andrej ^a   Hatzfeld, Mechthild ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Akt; Insulin signaling; Intercellular adhesion; Phosphorylation; Plakophilin

Indexed keywords

INSULIN; PLAKOPHILIN; PLANKOPHILIN 1; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HALF LIFE TIME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AKT; INSULIN SIGNALING; INTERCELLULAR ADHESION; PHOSPHORYLATION; PLAKOPHILIN;

CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; INSULIN; MASS SPECTROMETRY; PHOSPHORYLATION; PLAKOPHILINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84877963919     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.118992     Document Type: Article

References (77)

1. Altomare, D. A., Lyons, G. E., Mitsuuchi, Y., Cheng, J. Q. and Testa, J. R. (1998). Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene 16, 2407-2411.
2. Bader, A. G. and Vogt, P. K. (2004). An essential role for protein synthesis in oncogenic cellular transformation. Oncogene 23, 3145-3150.
3. Bass-Zubek, A. E., Godsel, L. M., Delmar, M. and Green, K. J. (2009). Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr. Opin. Cell Biol. 21, 708-716.
4. Behrens, J. (2000). Control of beta-catenin signaling in tumor development. Ann. N. Y. Acad. Sci. 910, 21-33; discussion 33-25.
5. Bergman, R. and Sprecher, E. (2005). Histopathological and ultrastructural study of ectodermal dysplasia/skin fragility syndrome. Am. J. Dermatopathol. 27, 333-338.
6. Bjornsti, M. A. and Houghton, P. J. (2004). Lost in translation: dysregulation of capdependent translation and cancer. Cancer Cell 5, 519-523.
7. Bonné, S., Gilbert, B., Hatzfeld, M., Chen, X., Green, K. J. and van Roy, F. (2003). Defining desmosomal plakophilin-3 interactions. J. Cell Biol. 161, 403-416.
8. Brembeck, F. H., Rosário, M. and Birchmeier, W. (2006). Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev. 16, 51-59.
9. Brennan, D., Peltonen, S., Dowling, A., Medhat, W., Green, K. J., Wahl, J. K., 3rd, Del Galdo, F. and Mahoney, M. G. (2012). A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene 31, 1636-1648.
10. Chen, X., Bonne, S., Hatzfeld, M., van Roy, F. and Green, K. J. (2002). Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling. J. Biol. Chem. 277, 10512-10522.
11. Cheng, G. Z., Park, S., Shu, S., He, L., Kong, W., Zhang, W., Yuan, Z., Wang, L. H. and Cheng, J. Q. (2008). Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr. Cancer Drug Targets 8, 2-6.
12. Cheung, I. Y., Feng, Y., Danis, K., Shukla, N., Meyers, P., Ladanyi, M. and Cheung, N. K. (2007). Novel markers of subclinical disease for Ewing family tumors from gene expression profiling. Clin. Cancer Res. 13, 6978-6983.
13. Chidgey, M. and Dawson, C. (2007). Desmosomes: a role in cancer? Br. J. Cancer 96, 1783-1787.
14. Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480.
15. Datta, S. R., Brunet, A. and Greenberg, M. E. (1999). Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927.
16. Delva, E., Jennings, J. M., Calkins, C. C., Kottke, M. D., Faundez, V. and Kowalczyk, A. P. (2008). Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J. Biol. Chem. 283, 18303-18313.
17. Dusek, R. L. and Attardi, L. D. (2011). Desmosomes: new perpetrators in tumour suppression. Nat. Rev. Cancer 11, 317-323.
18. Ersoy-Evans, S., Erkin, G., Fassihi, H., Chan, I., Paller, A. S., Sürücü, S. and McGrath, J. A. (2006). Ectodermal dysplasia-skin fragility syndrome resulting from a new homozygous mutation, 888delC, in the desmosomal protein plakophilin 1. J. Am. Acad. Dermatol. 55, 157-161.
19. Furukawa, C., Daigo, Y., Ishikawa, N., Kato, T., Ito, T., Tsuchiya, E., Sone, S. and Nakamura, Y. (2005). Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 65, 7102-7110.
20. Gillies, R. J., Didier, N. and Denton, M. (1986). Determination of cell number in monolayer cultures. Anal. Biochem. 159, 109-113.
21. Glaβ, M., Möller, B., Zirkel, A., Wächter, K., Hüttelmaier, S. and Posch, S. (2012). Cell migration analysis: Segmenting scratch assay images with level sets and support vector machines. Pattern Recognit. 45, 3154-3165.
22. Hakimelahi, S., Parker, H. R., Gilchrist, A. J., Barry, M., Li, Z., Bleackley, R. C. and Pasdar, M. (2000). Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2. J. Biol. Chem. 275, 10905-10911.
23. Hatzfeld, M. (2005). The p120 family of cell adhesion molecules. Eur. J. Cell Biol. 84, 205-214.
24. Hatzfeld, M. (2007). Plakophilins: Multifunctional proteins or just regulators of desmosomal adhesion? Biochim. Biophys. Acta 1773, 69-77.
25. Hatzfeld, M., Haffner, C., Schulze, K. and Vinzens, U. (2000). The function of plakophilin 1 in desmosome assembly and actin filament organization. J. Cell Biol. 149, 209-222.
26. Hofmann, I., Mertens, C., Brettel, M., Nimmrich, V., Schnölzer, M. and Herrmann, H. (2000). Interaction of plakophilins with desmoplakin and intermediate filament proteins: an in vitro analysis. J. Cell Sci. 113, 2471-2483.
27. Hofmann, I., Casella, M., Schnölzer, M., Schlechter, T., Spring, H. and Franke, W. W. (2006). Identification of the junctional plaque protein plakophilin 3 in cytoplasmic particles containing RNA-binding proteins and the recruitment of plakophilins 1 and 3 to stress granules. Mol. Biol. Cell 17, 1388-1398.
28. Hong, J. Y., Park, J. I., Cho, K., Gu, D., Ji, H., Artandi, S. E. and McCrea, P. D. (2010a). Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members. J. Cell Sci. 123, 4351-4365.
29. Hong, S., Troyanovsky, R. B. and Troyanovsky, S. M. (2010b). Spontaneous assembly and active disassembly balance adherens junction homeostasis. Proc. Natl. Acad. Sci. USA 107, 3528-3533.
30. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S. and Kikuchi, A. (1998). Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 17, 1371-1384.
31. Jennings, J. M., Tucker, D. K., Kottke, M. D., Saito, M., Delva, E., Hanakawa, Y., Amagai, M. and Kowalczyk, A. P. (2011). Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. J. Invest. Dermatol. 131, 706-718.
32. Keil, R., Kiessling, C. and Hatzfeld, M. (2009). Targeting of p0071 to the midbody depends on KIF3. J. Cell Sci. 122, 1174-1183.
33. Kolligs, F. T., Kolligs, B., Hajra, K. M., Hu, G., Tani, M., Cho, K. R. and Fearon, E. R. (2000). gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev. 14, 1319-1331.
34. Kowalczyk, A. P., Hatzfeld, M., Bornslaeger, E. A., Kopp, D. S., Borgwardt, J. E., Corcoran, C. M., Settler, A. and Green, K. J. (1999). The head domain of plakophilin-1 binds to desmoplakin and enhances its recruitment to desmosomes. Implications for cutaneous disease. J. Biol. Chem. 274, 18145-18148.
35. Kundu, S. T., Gosavi, P., Khapare, N., Patel, R., Hosing, A. S., Maru, G. B., Ingle, A., Decaprio, J. A. and Dalal, S. N. (2008). Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis. Int. J. Cancer 123, 2303-2314.
36. Kurzen, H., Münzing, I. and Hartschuh, W. (2003). Expression of desmosomal proteins in squamous cell carcinomas of the skin. J. Cutan. Pathol. 30, 621-630.
37. Lorch, J. H., Klessner, J., Park, J. K., Getsios, S., Wu, Y. L., Stack, M. S. and Green, K. J. (2004). Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J. Biol. Chem. 279, 37191-37200.
38. Mamane, Y., Petroulakis, E., LeBacquer, O. and Sonenberg, N. (2006). mTOR, translation initiation and cancer. Oncogene 25, 6416-6422.
39. McGrath, J. A. and Mellerio, J. E. (2010). Ectodermal dysplasia-skin fragility syndrome. Dermatol. Clin. 28, 125-129.
40. McGrath, J. A., McMillan, J. R., Shemanko, C. S., Runswick, S. K., Leigh, I. M., Lane, E. B., Garrod, D. R. and Eady, R. A. (1997). Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat. Genet. 17, 240-244.
41. McGrath, J. A., Hoeger, P. H., Christiano, A. M., McMillan, J. R., Mellerio, J. E., Ashton, G. H., Dopping-Hepenstal, P. J., Lake, B. D., Leigh, I. M., Harper, J. I. et al. (1999). Skin fragility and hypohidrotic ectodermal dysplasia resulting from ablation of plakophilin 1. Br. J. Dermatol. 140, 297-307.
42. Memmott, R. M. and Dennis, P. A. (2009). Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell. Signal. 21, 656-664.
43. Miyashita, Y. and Ozawa, M. (2007). Increased internalization of p120-uncoupled E-cadherin and a requirement for a dileucine motif in the cytoplasmic domain for endocytosis of the protein. J. Biol. Chem. 282, 11540-11548.
44. Moll, R., Cowin, P., Kapprell, H. P. and Franke, W. W. (1986). Desmosomal proteins: new markers for identification and classification of tumors. Lab. Invest. 54, 4-25.
45. Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N. and Rosen, N. (1998). Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 273, 29864-29872.
46. Nakatani, K., Sakaue, H., Thompson, D. A., Weigel, R. J. and Roth, R. A. (1999). Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem. Biophys. Res. Commun. 257, 906-910.
47. Narayana, N., Gist, J., Smith, T., Tylka, D., Trogdon, G. and Wahl, J. K. (2010). Desmosomal component expression in normal, dysplastic, and oral squamous cell carcinoma. Dermatol. Res. Pract. 2010, 649731.
48. Neuber, S., Mühmer, M., Wratten, D., Koch, P. J., Moll, R. and Schmidt, A. (2010). The desmosomal plaque proteins of the plakophilin family. Dermatol. Res. Pract. 2010, 101452.
49. Osaki, M., Oshimura, M. and Ito, H. (2004). PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9, 667-676.
50. Ostareck, D. H., Ostareck-Lederer, A., Shatsky, I. N. and Hentze, M. W. (2001). Lipoxygenase mRNA silencing in erythroid differentiation: The 39UTR regulatory complex controls 60S ribosomal subunit joining. Cell 104, 281-290.
51. Peng, X. D., Xu, P. Z., Chen, M. L., Hahn-Windgassen, A., Skeen, J., Jacobs, J., Sundararajan, D., Chen, W. S., Crawford, S. E., Coleman, K. G. et al. (2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17, 1352-1365.
52. Polakis, P. (2000). Wnt signaling and cancer. Genes Dev. 14, 1837-1851. Qiao, M., Sheng, S. and Pardee, A. B. (2008). Metastasis and AKT activation. Cell Cycle 7, 2991-2996.
53. Ramaswamy, S., Nakamura, N., Vazquez, F., Batt, D. B., Perera, S., Roberts, T. M. and Sellers, W. R. (1999). Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 96, 2110-2115.
54. Raught, B., Peiretti, F., Gingras, A. C., Livingstone, M., Shahbazian, D., Mayeur, G. L., Polakiewicz, R. D., Sonenberg, N. and Hershey, J. W. (2004). Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J. 23, 1761-1769.
55. Resnik, N., Sepcic, K., Plemenitas, A., Windoffer, R., Leube, R. and Veranic, P. (2011). Desmosome assembly and cell-cell adhesion are membrane raft-dependent processes. J. Biol. Chem. 286, 1499-1507.
56. Rickelt, S., Franke, W. W., Doerflinger, Y., Goerdt, S., Brandner, J. M. and Peitsch, W. K. (2008). Subtypes of melanocytes and melanoma cells distinguished by their intercellular contacts: heterotypic adherens junctions, adhesive associations, and dispersed desmoglein 2 glycoproteins. Cell Tissue Res. 334, 401-422.
57. Robertson, G. P. (2005). Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev. 24, 273-285.
58. Schmitt, C. J., Franke, W. W., Goerdt, S., Falkowska-Hansen, B., Rickelt, S. and Peitsch, W. K. (2007). Homo- and heterotypic cell contacts in malignant melanoma cells and desmoglein 2 as a novel solitary surface glycoprotein. J. Invest. Dermatol. 127, 2191-2206.
59. She, Q. B., Halilovic, E., Ye, Q., Zhen, W., Shirasawa, S., Sasazuki, T., Solit, D. B. and Rosen, N. (2010). 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell 18, 39-51.
60. Shin, S. S., Wall, B. A., Goydos, J. S. and Chen, S. (2010). AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell Melanoma Res 23, 103-111.
61. Sigismund, S., Confalonieri, S., Ciliberto, A., Polo, S., Scita, G. and Di Fiore, P. P. (2012). Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol. Rev. 92, 273-366.
62. Sklyarova, T., Bonné, S., D'Hooge, P., Denecker, G., Goossens, S., De Rycke, R., Borgonie, G., Bösl, M., van Roy, F. and van Hengel, J. (2008). Plakophilin-3- deficient mice develop hair coat abnormalities and are prone to cutaneous inflammation. J. Invest. Dermatol. 128, 1375-1385.
63. Sobolik-Delmaire, T., Reddy, R., Pashaj, A., Roberts, B. J. and Wahl, J. K., 3rd (2010). Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. J. Invest. Dermatol. 130, 2638-2646.
64. South, A. P. (2004). Plakophilin 1: an important stabilizer of desmosomes. Clin. Exp. Dermatol. 29, 161-167.
65. South, A. P., Wan, H., Stone, M. G., Dopping-Hepenstal, P. J., Purkis, P. E., Marshall, J. F., Leigh, I. M., Eady, R. A., Hart, I. R. and McGrath, J. A. (2003). Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability. J. Cell Sci. 116, 3303-3314.
66. Stahl, J. M., Sharma, A., Cheung, M., Zimmerman, M., Cheng, J. Q., Bosenberg, M. W., Kester, M., Sandirasegarane, L. and Robertson, G. P. (2004). Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res. 64, 7002-7010.
67. Steelman, L. S., Stadelman, K. M., Chappell, W. H., Horn, S., Bäsecke, J., Cervello, M., Nicoletti, F., Libra, M., Stivala, F., Martelli, A. M. et al. (2008). Akt as a therapeutic target in cancer. Expert Opin. Ther. Targets 12, 1139-1165.
68. Svitkin, Y. V., Herdy, B., Costa-Mattioli, M., Gingras, A. C., Raught, B. and Sonenberg, N. (2005). Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol. Cell. Biol. 25, 10556-10565.
69. Tokunaga, E., Oki, E., Egashira, A., Sadanaga, N., Morita, M., Kakeji, Y. and Maehara, Y. (2008). Deregulation of the Akt pathway in human cancer. Curr. Cancer Drug Targets 8, 27-36.
70. Tselepis, C., Chidgey, M., North, A. and Garrod, D. (1998). Desmosomal adhesion inhibits invasive behavior. Proc. Natl. Acad. Sci. USA 95, 8064-8069.
71. Valladares-Ayerbes, M., Díaz-Prado, S., Reboredo, M., Medina, V., Lorenzo- patino, M. J., Iglesias-Díaz, P., Haz, M., Pértega, S., Santamarina, I., Blanco, M. et al. (2010). Evaluation of plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients. Cancer Epidemiol. Biomarkers Prev. 19, 1432-1440.
72. Villaret, D. B., Wang, T., Dillon, D., Xu, J., Sivam, D., Cheever, M. A. and Reed, S. G. (2000). Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 110, 374-381.
73. Winn, R. A., Bremnes, R. M., Bemis, L., Franklin, W. A., Miller, Y. E., Cool, C. and Heasley, L. E. (2002). gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 21, 7497-7506.
74. Wolf, A. and Hatzfeld, M. (2010). A role of plakophilins in the regulation of translation. Cell Cycle 9, 2973-2978.
75. Wolf, A., Krause-Gruszczynska, M., Birkenmeier, O., Ostareck-Lederer, A., Hüttelmaier, S. and Hatzfeld, M. (2010). Plakophilin 1 stimulates translation by promoting eIF4A1 activity. J. Cell Biol. 188, 463-471.
76. Yap, A. S., Crampton, M. S. and Hardin, J. (2007). Making and breaking contacts: the cellular biology of cadherin regulation. Curr. Opin. Cell Biol. 19, 508-514.
77. Zanivan, S., Gnad, F., Wickström, S. A., Geiger, T., Macek, B., Cox, J., Fässler, R. and Mann, M. (2008). Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. J. Proteome Res. 7, 5314-5326.